SynthesisJournal of immunology research2020

Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.